End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3 NZD | -4.15% | -2.91% | -14.29% |
01/05 | AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV | MT |
24/04 | New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment | MT |
Evolution of the average Target Price on AFT Pharmaceuticals Limited
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AFT Stock
- Consensus AFT Pharmaceuticals Limited